Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NIH × Communication × Clear all

Phase

Status

Sponsor Class

OTHER 59 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 32 Prostatic Neoplasms 16 Lymphoma 14 Rectal Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 11 Leukemia 11 Uterine Cervical Neoplasms 10 Colorectal Neoplasms 10 Colonic Neoplasms 10 Sarcoma 9 Unspecified Adult Solid Tumor, Protocol Specific 8 Central Nervous System Neoplasms 8 Ovarian Neoplasms 7 Head and Neck Neoplasms 7 Brain Neoplasms 7 Pain 6 Neuroblastoma 6 Leukemia, Myeloid, Acute 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Ovarian Epithelial 6 Testicular Neoplasms 5 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Esophageal Neoplasms 5 Burkitt Lymphoma 5 Astrocytoma 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774254 2024-10-01

Reactions to Disease Risk Information

National Institutes of Health Clinical Center (CC)

Phase NA Completed

Communication, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡